Stocks · Health care · Pharmaceutical Preparations

SUPERNUS PHARMACEUTICALS, INC.

SUPN Clue Score33
United States Fiscal year ends December CIK 0001356576 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Padmanabh P. Bhatt
18 Mar 2026
Sr. VP of IP, CSO
Sold after exercise
412
$50.48
$20.80K
Padmanabh P. Bhatt
18 Mar 2026
Sr. VP of IP, CSO
Sold after exercise
6,838
$49.55
$338.82K
Padmanabh P. Bhatt
17 Mar 2026
Sr. VP of IP, CSO
Sold after exercise
22,290
$50.73
$1.13M
Padmanabh P. Bhatt
17 Mar 2026
Sr. VP of IP, CSO
Sold after exercise
27,710
$49.95
$1.38M
Padmanabh P. Bhatt
16 Mar 2026
Sr. VP of IP, CSO
Sold after exercise
15,886
$50.49
$802.08K
Padmanabh P. Bhatt
16 Mar 2026
Sr. VP of IP, CSO
Sold after exercise
34,114
$50.18
$1.71M
Jack A. Khattar
13 Mar 2026
President, CEO
Sold on a plan indirect
120
$51.75
$6.21K
Jack A. Khattar
13 Mar 2026
President, CEO
Sold on a plan indirect
10,742
$51.00
$547.84K
Jack A. Khattar
13 Mar 2026
President, CEO
Sold on a plan indirect
24,138
$50.09
$1.21M
Frederick M. Hudson
12 Mar 2026
Director
Sell
5,369
$50.61
$271.73K
William Todd Horich
10 Mar 2026
SVP, Commercial Operations
Sell
4,439
$55.00
$244.15K
William Todd Horich
9 Mar 2026
SVP, Commercial Operations
Sell
4,438
$54.00
$239.65K
Frank Mottola
9 Mar 2026
SVP, Chief Tech. Ops. Officer
Sell
1,623
$53.65
$87.07K
Georges Gemayel
6 Mar 2026
Director
Sold after exercise
8,787
$53.00
$465.71K
Georges Gemayel
5 Mar 2026
Director
Sell
10,000
$53.71
$537.10K
Georges Gemayel
23 Feb 2026
Director
Exercised, kept
15,000
$12.98
$194.70K
Bethany Sensenig
19 Feb 2026
Director
Sold after exercise
3,258
$51.27
$167.04K
Bethany Sensenig
19 Feb 2026
Director
Sold after exercise
1,217
$50.31
$61.23K
Frederick M. Hudson
9 Jan 2026
Director
Exercised, kept
15,000
$12.98
$194.70K
Frank Mottola
19 Dec 2025
SVP, Chief Tech. Ops. Officer
Sold after exercise
15,000
$50.47
$757.05K
Frank Mottola
19 Dec 2025
SVP, Chief Tech. Ops. Officer
Sold after exercise
5,000
$50.22
$251.10K
Padmanabh P. Bhatt
18 Dec 2025
Sr. VP of IP, CSO
Sold after exercise
710
$44.44
$31.55K
Charles W Newhall III
21 Nov 2025
Director
Exercised, kept
15,000
$12.98
$194.70K

What was left out

Form 4 filings counted 66
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 12
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 2,909,472
History held since 7 May 2012